These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17999430)

  • 21. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change of stretch reflex threshold in spasticity: effect of botulinum toxin injections.
    Stampacchia G; Bradaschia E; Rossi B
    Arch Ital Biol; 2004 May; 142(3):265-73. PubMed ID: 15260380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of spasticity in children with cerebral palsy.
    Verrotti A; Greco R; Spalice A; Chiarelli F; Iannetti P
    Pediatr Neurol; 2006 Jan; 34(1):1-6. PubMed ID: 16376270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
    Voller B; Földy D; Hefter H; Auff E; Schnider P
    Wien Klin Wochenschr; 2001; 113 Suppl 4():25-9. PubMed ID: 15506049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meaningful improvement in walking performance after Botulinum neurotoxin A (BoNT-A) in chronic spastic patients.
    Cioncoloni D; Taddei S; Bielli S; Annunziata P; Mazzocchio R
    NeuroRehabilitation; 2014; 34(1):185-92. PubMed ID: 24284465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin injection of the subscapularis muscle.
    Unlu E; Sen T; Umay E; Bal B; Elhan A; Cakci A
    J Clin Neurosci; 2010 Oct; 17(10):1265-6. PubMed ID: 20591673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity.
    Kong KH; Neo JJ; Chua KS
    Clin Rehabil; 2007 Jan; 21(1):28-35. PubMed ID: 17213238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Botulinum toxin injections and hypertonic upper limbs. Which functional results?].
    Ferrapie AL; Vieillart A; Saint-Cast Y; Menei P; Richard I
    Ann Readapt Med Phys; 2005 May; 48(4):172-9. PubMed ID: 15848259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The type A botulinum toxin in the treatment of spasticity in evolutive age.
    Roccella M
    Minerva Pediatr; 1999; 51(11-12):367-73. PubMed ID: 10768002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
    Kuo HC; Chancellor MB
    BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke.
    Farina S; Migliorini C; Gandolfi M; Bertolasi L; Casarotto M; Manganotti P; Fiaschi A; Smania N
    Funct Neurol; 2008; 23(2):87-91. PubMed ID: 18671909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial.
    Diniz de Lima F; Faber I; Servelhere KR; Bittar MFR; Martinez ARM; Piovesana LG; Martins MP; Martins CR; Benaglia T; de Sá Carvalho B; Nucci A; França MC
    Mov Disord; 2021 Jul; 36(7):1654-1663. PubMed ID: 33595142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin for hereditary spastic paraplegia: effects on motor and non-motor manifestations.
    Servelhere KR; Faber I; Martinez A; Nickel R; Moro A; Germiniani FMB; Moscovich M; Blume TR; Munhoz RP; Teive HAG; França MC
    Arq Neuropsiquiatr; 2018 Mar; 76(3):183-188. PubMed ID: 29809239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin for spasticity after stroke.
    Buitrago MM; Koolwijk I
    N Engl J Med; 2003 Jan; 348(3):258-9; author reply 258-9. PubMed ID: 12530438
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term effects of botulinum toxin A in children with cerebral palsy.
    Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y
    Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
    Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
    Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The application of botulinum toxin type A in the treatment of spastic paraparesis].
    Sobolewski P
    Przegl Lek; 2007; 64 Suppl 2():3-7. PubMed ID: 17953270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy.
    Moore AP; Ade-Hall RA; Smith CT; Rosenbloom L; Walsh HP; Mohamed K; Williamson PR
    Neurology; 2008 Jul; 71(2):122-8. PubMed ID: 18606966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved gait performance in a patient with hereditary spastic paraplegia after a continuous intrathecal baclofen test infusion and subsequent pump implantation: a case report.
    Heetla HW; Halbertsma JP; Dekker R; Staal MJ; van Laar T
    Arch Phys Med Rehabil; 2015 Jun; 96(6):1166-9. PubMed ID: 25626112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.